Perdagangan Gilead GILD

Gilead diagram langsung

Dasar-dasar Instrumen

Weekly Search
Weekly
Daily
Tanggal Tutup Ubah Ubah (%) Buka Tinggi Rendah

Gilead news

Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Berita Terkini

Tampilkan lebih banyak
Ava Grace 2025 Aug 07, 05:20

Israel Gaza Conflict: Is a New Offensive on the Horizon?

Sophia Claire 2025 Aug 07, 02:20

Fed Vacancy: Will Trump Seek to Install a Powell Successor?

Liam James 2025 Aug 07, 01:20

Lula Rejects 'Humiliation', Weighs Options Against Trump Tariffs

Ava Grace 2025 Aug 06, 15:20

Trump Imposes Tariffs on India Over Russian Energy Imports Amid Ukraine Tensions

Liam James 2025 Aug 06, 14:20

Kashkari Hints at Possible Near-Term Rate Cut Amidst Economic Slowdown

Emma Rose 2025 Aug 06, 13:20

Global Stock Markets Defy Recession Fears: AI and Liquidity Fuel Rally

Ava Grace 2025 Aug 06, 11:20

Trump's Tariffs on Russian Oil: Potential Impact on US and Global Economy

Noah Lee 2025 Aug 06, 10:20

Berkshire Hathaway's Underperformance: Succession Concerns and Market Shifts

Info

Spread

0.69

Spread (%)

0.6275 %

Leverage

1:10

Bunga Overnight Beli

-0.0597 %

Bunga Overnight Jual

-0.0292 %

Mata Uang

USD

Jam Trading

Pasar tutup

Kamis

13:31 - 19:59

Senin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Jumat

13:31-19:59

Analisis dan Statistik

Buka

---

Sebelumnya Tutup

---

52 Minggu Tigg/Rdh

--- – ---

Kapitalisasi Pasar

137180594176

Saham yang Beredar

1243929984

Tanggal Penghasilan (Berikutnya)

2013-01-28

Hasil Div

2025-06-27

Tanggal Non-Dividen

2025-06-13

Proyeksi tingkat dividen tahunan

3.16

Proyeksi hasil dividen tahunan

0.0287

EPS

4.76

Pelajari lebih lanjut tentang instrumen ini

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

latest_education_articles

Tampilkan lebih banyak
Trustpilot